AF647 Anti-Human CD8a Antibody[OKT-8]

The AF647 Anti-Human CD8A Antibody, also known as OKT-8, is a highly specific and reliable tool for the detection and analysis of CD8A expression in human samples. This monoclonal antibody is designed to target the CD8A antigen, a cell surface glycoprotein expressed on cytotoxic T cells and a subset of natural killer cells.

With its exceptional specificity, the AF647 Anti-Human CD8A Antibody ensures accurate identification and quantification of CD8A-positive cells in various research applications, including immunohistochemistry, flow cytometry, and immunofluorescence. Its superior performance guarantees reliable and reproducible results, making it an indispensable tool for researchers in the field of immunology.

The AF647 Anti-Human CD8A Antibody offers several advantages over other antibodies on the market. Its high affinity for the CD8A antigen allows for efficient binding and detection, even at low concentrations. This antibody exhibits minimal cross-reactivity with other antigens, ensuring minimal background noise and enhanced specificity. Additionally, it demonstrates excellent stability and consistency, enabling consistent performance across multiple experiments.

This product is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size, allowing for easy handling and storage. The AF647 Anti-Human CD8A Antibody is manufactured under strict quality control standards, ensuring batch-to-batch consistency and reliability.

In summary, the AF647 Anti-Human CD8A Antibody, also known as OKT-8, is a highly specific and reliable tool for the detection and analysis of CD8A expression in human samples. With its exceptional performance and numerous advantages, this antibody is an essential resource for researchers in the field of immunology, enabling accurate and reproducible results in various applications.